Correlation between pre-treatment quasispecies complexity and treatment outcome in chronic HCV genotype 3a.
AffiliationMolecular Virology Diagnostic & Research Laboratory, Department of Medicine,, Clinical Sciences Building, Cork University Hospital, Cork, Ireland., email@example.com
Antiviral Agents/administration & dosage/*therapeutic use
Drug Therapy, Combination
Hepatitis C, Chronic/*drug therapy/virology
Interferon-alpha/administration & dosage/*therapeutic use
Molecular Sequence Data
Polyethylene Glycols/administration & dosage/*therapeutic use
Reverse Transcriptase Polymerase Chain Reaction
Ribavirin/administration & dosage/*therapeutic use
Sequence Analysis, DNA
MetadataShow full item record
CitationVirol J. 2008 Jul 9;5:78.
AbstractPre-treatment HCV quasispecies complexity and diversity may predict response to interferon based anti-viral therapy. The objective of this study was to retrospectively (1) examine temporal changes in quasispecies prior to the start of therapy and (2) investigate extensively quasispecies evolution in a group of 10 chronically infected patients with genotype 3a, treated with pegylated alpha2a-Interferon and ribavirin. The degree of sequence heterogeneity within the hypervariable region 1 was assessed by analyzing 20-30 individual clones in serial serum samples. Genetic parameters, including amino acid Shannon entropy, Hamming distance and genetic distance were calculated for each sample. Treatment outcome was divided into (1) sustained virological responders (SVR) and (2) treatment failure (TF). Our results indicate, (1) quasispecies complexity and diversity are lower in the SVR group, (2) quasispecies vary temporally and (3) genetic heterogeneity at baseline can be use to predict treatment outcome. We discuss the results from the perspective of replicative homeostasis.
- HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin.
- Authors: Abbate I, Lo Iacono O, Di Stefano R, Cappiello G, Girardi E, Longo R, Ferraro D, Antonucci G, Di Marco V, Solmone M, Craxì A, Ippolito G, Capobianchi MR
- Issue date: 2004 May
- Quasispecies as predictive factor of rapid, early and sustained virological responses in chronic hepatitis C, genotype 1, treated with peginterferon-ribavirin.
- Authors: Salmerón J, Casado J, Rueda PM, Lafuente V, Diago M, Romero-Gómez M, Palacios A, León J, Gila A, Quiles R, Rodriguez L, Ruiz-Extremera A
- Issue date: 2008 Apr
- Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4.
- Authors: Zekri AR, El-Din HM, Bahnassy AA, Khaled MM, Omar A, Fouad I, El-Hefnewi M, Thakeb F, El-Awady M
- Issue date: 2007 Feb 14
- Heterogeneity of HVR-1 quasispecies is predictive of early but not sustained virological response in genotype 1b-infected patients undergoing combined treatment with PEG- or STD-IFN plus RBV.
- Authors: Abbate I, Cappiello G, Lo Iacono O, Longo R, Ferraro D, Antonucci G, Di Marco V, Di Stefano R, Craxì A, Solmone MC, Spanò A, Ippolito G, Capobianchi MR
- Issue date: 2003 Apr-Jun
- Quasispecies of hepatitis C virus genotype 1 and treatment outcome with peginterferon and ribavirin.
- Authors: Jardim AC, Yamasaki LH, de Queiróz AT, Bittar C, Pinho JR, Carareto CM, Rahal P, Mello IM
- Issue date: 2009 Jul